MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2026 International Congress

    Compassion Focussed Therapy Groups for People with Parkinson’s and their care-partners

    O. Batterbee, T. Edwards, B. Mohamed, J. Adenwalla, R. Lewis-Morton (Cardiff, United Kingdom)

    Objective: To evaluate the psychological outcomes of a Compassion-Focused Therapy (CFT) group for people with Parkinson’s (PwP), including an additional carer-only session. Background: Parkinson’s is…
  • 2026 International Congress

    Prevalence and Treatment Patterns of Anxiety Symptoms in Parkinson’s Disease

    J. Lam, K. Tosefsky, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To examine the prevalence of clinically significant anxiety symptoms, their overlap with depressive symptoms, and associated pharmacologic treatment patterns in Parkinson's disease (PD). Background:…
  • 2026 International Congress

    Relationship Between Psychosocial Factors and Tremor Severity in Essential Tremor

    N. Başpınar, T. Akıncı, G. Yüksel (Istanbul, Turkey)

    Objective: To examine the relationship between psychosocial factors and tremor severity in patients with essential tremor (ET). Background: Essential tremor is one of the most…
  • 2026 International Congress

    Effects of Botulinum Toxin Therapy on Depression, Anxiety, Pain, and Quality of Life in Patients with Dystonia

    N. Başpınar, Z. Irmak, A. Ersöz, T. Akıncı, G. Yüksel (Istanbul, Turkey)

    Objective: To evaluate changes in depression,anxiety,pain, and quality of life alongside motor improvement in patients with dystonia treated with botulinum toxin(BoNT). Background: Dystonia is a…
  • 2026 International Congress

    Resting-state functional network alterations in early Parkinson’s disease anxiety: a 7T MRI study

    G. Carey, S. Michielse, K. Dujardin, M. Kuijf, A. Leentjens (Reims, France)

    Objective: To investigate alterations in functional connectivity (FC) within and between key resting-state networks in early Parkinson’s disease patients with anxiety, using 7-Tesla (7T) MRI.…
  • 2026 International Congress

    The Anxiolytic Effect of Cannabidiol and Tetrahydrocannabinol in a Reserpine Model of Parkinson’s Disease in Mice

    H. Tanko, T. Muhammad, A-S. Isa (Zaria, Nigeria)

    Objective: This study evaluated the anxiolytic effects of CBD, THC, and their combination in a reserpine-induced Parkinson’s mouse model using the Elevated Plus Maze (EPM)…
  • 2026 International Congress

    Does Fall-Related Activity Avoidance Differ between people with Parkinson’s disease versus Cognitively Unimpaired Controls?

    M. Lindh-Rengifo, E. Franzén, M. Landers, E. Stomrud, M. Nilsson (Malmö, Sweden)

    Objective: investigate whether fall-related activity avoidance differs between people with Parkinson’s disease (PD) versus cognitively unimpaired controls (CU) without any significant neurological disease. Background: Although…
  • 2026 International Congress

    Integrating Psychology into a Parkinson’s Disease Service – Evaluating Need

    R. Lewis-Morton, O. Batterbee, T. Edwards, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

    Objective: This service evaluation aimed to assess the need for integrated psychological support within a Parkinson’s disease (PD) service by examining referral rates, presenting psychological…
  • 2026 International Congress

    Diagnosis and Treatment of Occult Psychogenic Movement Disorder Without Mood Disorder: A Case Report

    H. Liang, A. Karimova, C. Liang (Almaty, Kazakhstan)

    Objective: This case report describes a 17-year-old female with occult psychogenic movement disorder (PMD) presenting with involuntary tremor and abnormal somatic movement as core symptoms,…
  • 2025 International Congress

    Integrating the Collaborative Care Mental Health Model into Virtual Parkinson’s Disease Care

    E. Ferluga, E. Anderson, N. Flanagan, D. Geraldi-Samara, J. Riser, K. Brendle (Chicago, USA)

    Objective: In Parkinson’s Disease (PD), neuropsychiatric symptoms start in the prodromal stage.  Increased rates of depression and anxiety in PD have been associated with living…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 21
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley